| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2026 1st Quarter - Report |
MR. DAVID FRIEDMAN | OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WEST… | $33,750 | |
| 2026 1st Quarter - Report |
MR. DAVID FRIEDMAN | TEVA PHARMACEUTICALS USA, INC. | $250,000 | |
| 2026 AMENDED |
MR. DAVID FRIEDMAN | OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WEST… | — | |
| 2026 Registration |
MR. DAVID FRIEDMAN | OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WEST… | — | |
| 2025 4th Quarter - Report |
MR. DAVID FRIEDMAN | TEVA PHARMACEUTICALS USA, INC. | $200,000 | |
| 2025 Registration |
MR. DAVID FRIEDMAN | TEVA PHARMACEUTICALS USA, INC. | — |